FFA
JBIO

Farther Finance Advisors’s Jade Biosciences JBIO Stock Holding History

Farther Finance Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Sell
66
-12
-15% -$250 ﹤0.01% 5269
2026
Q1 		$1.25K Buy
78
+1
+1% +$14 ﹤0.01% 5040
2025
Q4 		$1.19K Hold
77
– – ﹤0.01% 4870
2025
Q3 		$665 Buy
77
+61
+381% +$498 ﹤0.01% 4471
2025
Q2 		$160 Buy
+16
New +$545 ﹤0.01% 4243

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Farther Finance Advisors's JBIO Position: Q2 2026 in Review

Farther Finance Advisors reduced its Jade Biosciences (JBIO) stake by 15% in Q2 2026, selling an estimated $250 and leaving 66 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #5269.

Farther Finance Advisors first reported a position in JBIO in Q2 2025 and has held it in 5 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Farther Finance Advisors held 66 shares of Jade Biosciences worth $1.46K as of Q2 2026.
  • Farther Finance Advisors sold 12 Jade Biosciences shares in Q2 2026, an estimated $250.
  • Jade Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5269 holding.
  • Farther Finance Advisors first reported a position in Jade Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.